SYK and hepatitis A virus infection: Especially, the activation of SYK in peripheral blood mononuclear cells and inflammatory macrophages is enhanced in patients with hepatitis, suggesting the potential of non-hepatic SYK as therapeutic target (Figure 2C) [40, 41].